Serving Diabetes Patients is a Smart Business Move for Pharmacies
Published Online: Thursday, December 12, 2013
In this video, Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, explains why going out of your way to serve diabetes patients can help grow your pharmacy’s business. This video was shot at the National Community Pharmacists Association 115th Annual Convention in Orlando.
The FDA today approved dulaglutide (Trulicity), a once-weekly injectable therapy indicated to improve blood sugar control in adults with type 2 diabetes.
Combined with bolus insulin aspart (NovoLog), insulin degludec (Tresiba) improves long-term glycemic control in children and adolescents with type 1 diabetes.
Results show pharmacists and other healthcare providers can work together to successfully empower patients disproportionately affected by diabetes to achieve improved clinical outcomes.